Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3006 |
|
| Actual shortage: | 229 (8%) | |
| Anticipated shortage: | 21 (1%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2747 (91%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
27 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-ARIPIPRAZOLE | 10MG | TABLET | Resolved | 2023-02-23 | 2023-03-16 | 185477 |
| APO-CEPHALEX | 500MG | TABLET | Resolved | 2023-02-23 | 2023-03-02 | 185480 |
| APO-AMOXI CLAV | 125MG 250MG | TABLET | Resolved | 2023-02-23 | 2023-03-16 | 185483 |
| APO-LABETALOL | 200MG | TABLET | Resolved | 2023-02-23 | 2023-03-02 | 185489 |
| APO-PRAZO TAB 5MG | 5MG | TABLET | Actual shortage | 2023-03-02 | 2024-03-27 | 185924 |
| OVIMA 28 | 30MCG 150MCG | TABLET | Resolved | 2023-03-02 | 2023-03-23 | 185933 |
| APO-CEPHALEX | 250MG | TABLET | Resolved | 2023-03-02 | 2023-04-14 | 185939 |
| APO-NAPROXEN | 500MG | TABLET | Resolved | 2023-03-02 | 2023-05-06 | 185942 |
| APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE | 500MG 50MG | TABLET | Resolved | 2023-03-02 | 2023-07-27 | 185948 |
| APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE | 850MG 50MG | TABLET | Resolved | 2023-03-02 | 2023-10-06 | 185951 |
| APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE | 850MG 50MG | TABLET | Resolved | 2023-03-02 | 2023-10-06 | 185954 |
| APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE | 1000MG 50MG | TABLET | Resolved | 2023-03-02 | 2023-07-27 | 185957 |
| APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE | 1000MG 50MG | TABLET | Resolved | 2023-03-02 | 2023-07-27 | 185961 |
| APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE | 1000MG 50MG | TABLET | Resolved | 2023-03-02 | 2023-07-27 | 185964 |
| APO-SOTALOL | 160MG | TABLET | Resolved | 2023-03-09 | 2023-06-29 | 186569 |
| APO-ALENDRONATE/VITAMIN D3 | 2800UNIT 70MG | TABLET | Resolved | 2023-03-09 | 2023-04-21 | 186572 |
| APO-PERINDOPRIL-INDAPAMIDE | 8MG 2.5MG | TABLET | Avoided shortage | 2023-03-09 | 2023-09-15 | 186580 |
| APO-PERINDOPRIL-INDAPAMIDE | 8MG 2.5MG | TABLET | Resolved | 2023-03-09 | 2023-09-22 | 186583 |
| APO-LETROZOLE | 2.5MG | TABLET | Resolved | 2023-03-09 | 2023-03-16 | 186589 |
| APO-CARVEDILOL | 12.5MG | TABLET | Resolved | 2023-03-16 | 2023-04-27 | 187223 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
| APO-CETIRIZINE | Discontinued | 2018-05-31 | 2018-05-31 | 50998 | ||
| APO-AMOXI CLAV 125MG/31.25MG PER 5ML | Discontinued | 2018-09-07 | 2018-09-15 | 60241 | ||
| APO-CYCLOSPORINE ORAL SOLUTION | Discontinued | 2018-09-07 | 2018-09-15 | 60408 | ||
| APO-FAMOTIDINE TAB 20MG USP | Discontinued | 2018-09-07 | 2018-09-15 | 60477 | ||
| APO-FAMOTIDINE TAB 40MG USP | Discontinued | 2018-09-07 | 2018-09-15 | 60480 | ||
| APO-FENTANYL MATRIX | Discontinued | 2018-09-07 | 2018-09-15 | 60494 | ||
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
| APO-LATANOPROST-TIMOP | Discontinued | 2018-09-07 | 2018-09-15 | 60572 | ||
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60735 | ||
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60738 | ||
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60741 | ||
| APO-RIZATRIPTAN RPD | Discontinued | 2018-09-08 | 2019-04-02 | 60756 | ||
| APO-SILDENAFIL R | Discontinued | 2018-09-08 | 2018-09-15 | 60787 | ||
| APO-AMOXI CLAV 125MG/31.25MG PER 5ML | Discontinued | 2018-12-21 | 2018-12-24 | 70347 | ||
| APO-TIMOP | Discontinued | 2019-01-02 | 2019-01-02 | 70818 | ||
| ACID CONTROL | Discontinued | 2019-01-03 | 2019-01-03 | 70906 | ||
| APO-OFLOXACIN | Discontinued | 2019-01-03 | 2019-01-03 | 71017 | ||
| APO-TIMOP GEL | Discontinued | 2019-01-03 | 2019-01-03 | 71020 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71029 |